✉news HealthMedicine first seen 10 h ago, last 9 h ago, peak #26
CRISPR Therapy Lowers Cholesterol for a Year
Original: CRISPR Cuts Cholesterol for a Year
A CRISPR-based gene-editing treatment has been reported to reduce cholesterol, with the effect lasting up to a year after a single intervention. The development points to a potential one-time alternative to daily statins for managing cardiovascular risk. Observers in the medical field are weighing the promise of durable cholesterol reduction against questions about long-term safety, cost and access.
Why now: A long-lasting, single-treatment gene-editing result for cholesterol is a significant advance in cardiovascular medicine.
CRISPRcholesterolcardiovascular disease
Rank over time, top of the chart is #1. 2 snapshots from 10 h ago to 9 h ago.
Evidence
- CRISPR Cuts Cholesterol for a Year · The Medicine Maker
API: https://socialmediatrends-api.osmike.com/v1/trends/2220825